Keyphrases
Cancer Cells
66%
Cancer Immunotherapy
100%
Cancer Types
33%
Cancer-specific Promoter
33%
Checkpoint Inhibitors
33%
Chemokines
33%
Clinical Trials
33%
Gene Circuits
100%
Immune Regulator
33%
Immune Suppression
33%
Immune Toxicity
33%
Immunogenic
33%
Immunomodulator
66%
Immunomodulatory
33%
Immunomodulatory Genes
100%
Immunostimulator
66%
In Vivo Efficacy
33%
Inhibitor Antibodies
33%
Lentiviral
33%
Mouse Survival
33%
Mouse Tumor Model
33%
Output-only
33%
Prolonged Survival
33%
RNA-based
100%
Specific Expression
66%
Surface Proteins
33%
Synthetic RNA
100%
Systemic Delivery
33%
T-cell Mediated
66%
Tumor
33%
Tumor Antigen
33%
Tumor Reduction
33%
Tumor-specific
66%
Medicine and Dentistry
Cancer Cell
100%
Cancer Immunotherapy
100%
Cancer Model
50%
Cancer Types
50%
Cell Surface Protein
50%
Chemokine
50%
Clinical Trial
50%
Cytokine
50%
Disease
50%
Immunity
50%
Immunomodulating Agent
100%
Immunosuppressive Treatment
50%
Immunotoxicity
50%
In Vitro
50%
Malignant Neoplasm
100%
Neoplasm
100%
Promoter Region
100%
Specific Tumor
100%
T Cell
100%
Tumor Antigen
50%
Immunology and Microbiology
Cancer Cell
100%
Cancer Immunotherapy
100%
Cell Surface
50%
Chemokine
50%
Cytokine
50%
Immunity
100%
Immunology
50%
Immunomodulating Drugs
100%
Promoter Region
100%
T Cell
100%
Tumor Antigen
50%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Cancer Immunotherapy
100%
Cell Surface Protein
50%
Chemokine
50%
Clinical Trial
50%
Cytokine
50%
Immunity
100%
Promoter Region
100%
RNA
100%
T Cell
100%
Tumor Antigen
50%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Model
14%
Cell Surface Protein
14%
Chemokine
14%
Clinical Trial
14%
Cytokine
14%
Disease
14%
Immunomodulating Agent
28%
Immunotherapy
100%
Malignant Neoplasm
100%
Neoplasm
57%
Tumor Antigen
14%